Celsion Corporation Advances Proof of Concept to Non-human Primate Challenge Study Against SARS-CoV-2 with In-Process Vaccine Candidate

2 years ago

Preclinical results demonstrate safe and efficient immune response with vaccine development showing promise of neutralizing activity for a range of…

Franciscan Health Achieves Center of Excellence Status for Cardio-Oncology Care

2 years ago

Franciscan Health Franciscan Health Indianapolis INDIANAPOLIS, Indiana, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Franciscan Health joins an elite group of…

Amedisys Announces Fourth Quarter and Year End Earnings Release and Conference Call Date

2 years ago

BATON ROUGE, La., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice,…

ImmixBio Initiates IMX-110 GMP Manufacturing Scale-Up, Potentially Accelerating Clinical Trial Data

2 years ago

ImmixBio Initiates IMX-110 GMP Manufacturing Scale-Up, Potentially Accelerating Clinical Trial Data Immix Biopharma, Inc. (NASDAQ:IMMX) Manufactured IMX-110 to be utilized…

Brain Scientific Issues Shareholder Letter and Corporate Update

2 years ago

New CEO foresees revenue growth from commercial medical product launches in $4 billion addressable marketNEW YORK, Jan. 31, 2022 (GLOBE…

Immutep to Present at February Investor Conferences

2 years ago

SYDNEY, AUSTRALIA, Jan. 31, 2022 (GLOBE NEWSWIRE) --  Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology…

Keros Therapeutics Appoints Christopher Rovaldi as Chief Operating Officer

2 years ago

LEXINGTON, Mass., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on…

Universe Pharmaceuticals INC Reports Fiscal Year 2021 Financial Results

2 years ago

Ji’an, Jiangxi, China, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and…

180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Shareholders

2 years ago

PALO ALTO, Calif., Jan. 31, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF, “180 Life Sciences” or the "Company"),…

Zenith Epigenetics Announces Appointment to Board of Directors and Provides Clinical Update

2 years ago

CALGARY, Alberta, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Zenith Capital Corp. (“Zenith” or the “Company”) today announced the appointment of…